- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SONNET BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 02.06. | Sonnet Biotherapeutics erhält Delisting-Mitteilung von der NASDAQ | 5 | Investing.com Deutsch | ||
| 02.06. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.05. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 01.05. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit | 2 | GlobeNewswire (USA) | ||
| 16.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Releases Virtual Investor "What This Means" Segment | 4 | GlobeNewswire (USA) | ||
| 04.04. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 04.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest ... | 258 | GlobeNewswire (Europe) | Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®) The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg in combination... ► Artikel lesen | |
| 01.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Announces Release of Corporate Update Video | 3 | GlobeNewswire (USA) | ||
| 01.04. | Sonnet BioTherapeutics ernennt Interims-CEO nach dem Tod des Gründers | 2 | Investing.com Deutsch | ||
| 01.04. | Sonnet BioTherapeutics appoints interim CEO after founder's death | 3 | Investing.com | ||
| 01.04. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D. | 184 | GlobeNewswire (Europe) | PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted... ► Artikel lesen | |
| 26.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.03. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas | 209 | GlobeNewswire (Europe) | SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy... ► Artikel lesen | |
| 19.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.03. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant ... | 200 | GlobeNewswire (Europe) | Company advancing development of its modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable... ► Artikel lesen | |
| 26.02. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors | 4 | GlobeNewswire (USA) | ||
| 26.02. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.02. | Sonnet BioTherapeutics advances novel ADC platform | 1 | Investing.com | ||
| 19.02. | Sonnet BioTherapeutics macht Fortschritte bei neuartiger ADC-Plattform | 1 | Investing.com Deutsch | ||
| 19.02. | Sonnet BioTherapeutics Holdings, Inc.: Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline ... | 122 | GlobeNewswire (Europe) | Building on proven targeting of the FHAB domain, Sonnet's ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR) An epidermal growth factor receptor 2 (HER2) ADC... ► Artikel lesen |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KRAFT HEINZ | 21,865 | -0,27 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
| BEYOND MEAT | 2,867 | -3,11 % | BEYOND MEAT, INC. - 8-K, Current Report | ||
| MODERN PLANT BASED FOODS | 0,025 | -23,64 % | Modern Plant Based Foods Inc (2): Modern Plant Based Foods arranges $230,000 financing | ||
| LUCKIN COFFEE | 31,200 | 0,00 % | Luckin Coffee opens first US stores, stepping onto Starbucks' home turf | ||
| SUNWIN STEVIA INTERNATIONAL | 0,014 | 0,00 % | SUNWIN STEVIA INTERNATIONAL, INC. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| YUM! BRANDS | 125,75 | 0,00 % | Märkte am Morgen: Heidelberg Materials, BYD, Nvidia, Aerovironment, Yum! Brands, Micron Technology | Starke Zahlen von Micron: Gewinn und Umsatz übertreffen die Erwartungen deutlich, auch der Ausblick überzeugt. Shell sorgt für Schlagzeilen - angebliche Gespräche über eine 80-Milliarden-Dollar-Übernahme... ► Artikel lesen | |
| CHIPOTLE MEXICAN GRILL | 47,305 | -0,77 % | Chipotle Mexican Grill Crosses Above Key Moving Average Level | ||
| KROGER | 61,06 | +0,28 % | Gamechanger-News: Diese Aktie zündet den nächsten Turbo: Neue Tochterfirma könnte alles verändern! | ||
| OATLY GROUP | 10,100 | +0,50 % | Starke News am Morgen: Veganz geht nach Kanada! Mit Tech-Deal im Milliardenmarkt - kommt jetzt der Kursausbruch? | ||
| DOMINOS PIZZA INC | 381,70 | -0,20 % | DOMINOS PIZZA INC - 8-K, Current Report | ||
| VILLAGE FARMS | 0,951 | +2,26 % | Village Farms International, Inc.: Village Farms International Regains NASDAQ Compliance | VANCOUVER, British Columbia, June 09, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today announced that it received formal notice from... ► Artikel lesen | |
| BLENDER BITES | 0,128 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| CAVA GROUP | 84,47 | 0,00 % | Can CAVA's Measured Marketing Strategy Fuel the Next Phase of Growth? | ||
| SWEETGREEN | 14,890 | 0,00 % | Sweetgreen, Inc. - 8-K, Current Report | ||
| FIRST WATCH RESTAURANT GROUP | 16,060 | 0,00 % | First Watch Restaurant Group, Inc. Reports Q1 2025 Financial Results | Total revenues increased 16.4%Net loss of $(0.8) million and Adjusted EBITDA of $22.8 million13 new system-wide restaurants opened in 10 states BRADENTON, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- First... ► Artikel lesen |
Das Unternehmen SONNET BIOTHERAPEUTICS HOLDINGS INC kann der Branche Nahrungsmittel/Agrar zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,170 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONNET BIOTHERAPEUTICS HOLDINGS INC finden Sie auf Wallstreet Online.